Bone Density Treatments: Options and What to Expect:

Bone density treatments address osteoporosis and osteopenia—conditions where bones become weak and prone to fracture. Osteoporosis affects millions in the UK, particularly postmenopausal women and older adults; one in two women and one in five men over 50 will fracture a bone due to osteoporosis. Treatments include bisphosphonates (alendronate, risedronate, zoledronic acid), which slow bone loss; denosumab, a monoclonal antibody that inhibits bone breakdown; and anabolic agents (teriparatide, romosozumab), which build new bone. Calcium, vitamin D, and weight-bearing exercise support all treatments and are essential for bone health. Left untreated, osteoporosis leads to painful and disabling fractures—hip fractures in particular have high morbidity and mortality. Early diagnosis and treatment can prevent or delay these outcomes.

Diagnosis and Monitoring

DEXA Scans and BMD

Dual-energy X-ray absorptiometry (DEXA) scans measure bone mineral density (BMD) at the hip and spine. Results are reported as T-scores (compared to young adult peak) and Z-scores (compared to age-matched peers). A T-score of -2.5 or below indicates osteoporosis; -1 to -2.5 indicates osteopenia. DEXA is quick, low-radiation, and the gold standard for diagnosis. The scan takes about 10–15 minutes; you lie fully clothed on a table while the machine passes over you. No preparation is usually needed. DEXA is available on the NHS for those at risk; private scans cost around £100–£200. Your GP can advise on whether you need a scan based on your age, risk factors, and any previous fractures.

FRAX and Fracture Risk

The FRAX tool estimates 10-year probability of hip and major osteoporotic fracture using age, sex, BMD (if available), and risk factors (prior fracture, family history, smoking, alcohol, steroids). It guides treatment decisions—NICE recommends treatment when fracture risk exceeds certain thresholds. Repeat DEXA scans (typically every 2–3 years) track response to treatment.

Lifestyle, Medication, and Duration

Nutrition and Exercise

Calcium (700–1200 mg daily from diet or supplements) and vitamin D (400–800 IU, or more if deficient) are foundational. Weight-bearing exercise (walking, dancing, resistance training) stimulates bone formation. Fall prevention—removing trip hazards, improving lighting, balance exercises—reduces fracture risk. Smoking and excess alcohol worsen bone loss.

Treatment Duration and Drug Holidays

Bisphosphonate treatment is typically 5 years orally or 3 years IV; reassessment guides continuation or drug holiday. Denosumab requires ongoing injections; stopping abruptly can cause rebound vertebral fractures, so transition planning is critical. Anabolic agents are usually limited to 1–2 years. Your specialist will tailor duration to your risk profile and response.

Medication Options in Detail

Bisphosphonates

Alendronate and risedronate are taken weekly orally; zoledronic acid is given once yearly by IV infusion. Oral bisphosphonates must be taken on an empty stomach with a full glass of water; remain upright for 30 minutes to reduce oesophageal irritation. Side effects include flu-like symptoms (especially with IV) and rarely osteonecrosis of the jaw or atypical femoral fractures. Regular dental check-ups are advised.

Denosumab and Anabolic Agents

Denosumab is a twice-yearly subcutaneous injection; it's useful when bisphosphonates aren't tolerated or are contraindicated (e.g. kidney disease). Teriparatide (daily injection) and romosozumab (monthly) build bone and are reserved for high-risk patients. They're usually followed by a bisphosphonate to maintain gains. Your GP or rheumatologist will discuss the pros and cons of each option.

When to Seek Treatment

NICE guidelines recommend treatment for those with a T-score of -2.5 or below, or for those with osteopenia plus a high FRAX score. A prior fragility fracture (e.g. wrist, hip, spine) significantly increases future risk and often warrants treatment. Steroid users, those with a family history of hip fracture, and people with conditions affecting bone (e.g. inflammatory bowel disease, coeliac disease) may need earlier assessment. Your GP can refer you for a DEXA scan and fracture risk assessment. Early intervention reduces the likelihood of debilitating fractures later in life.

Monitoring and Follow-Up

Repeat DEXA scans every 2–3 years (or more frequently if high risk) to monitor response. Bone density may stabilise or improve with treatment; lack of improvement may prompt a change in medication. Blood tests for calcium, vitamin D, and kidney function are typically done at baseline and periodically. Report any new fractures, dental issues, or unusual thigh pain to your doctor—these can indicate medication-related complications. Osteoporosis is a chronic condition; ongoing management, not just initial treatment, is key to long-term outcomes.

Support and Resources

The Royal Osteoporosis Society (ROS) provides information, support, and local groups for those with osteoporosis. Their website has resources on diet, exercise, and treatment options. Your GP or rheumatologist can refer you to specialist services if needed. Falls prevention programmes—often run by local authorities or NHS trusts—offer balance assessments and exercises. Making your home safer (removing trip hazards, improving lighting, installing grab rails) reduces fracture risk. Family and carers can find support through the ROS and Carers UK. Dietitians can advise on calcium-rich foods and vitamin D supplementation. Physiotherapy helps with balance and strength—both important for fracture prevention. Don't hesitate to ask your healthcare team for referrals to these services.